JOSE VERA: Open Payments
NPI 1669702270 · SANFORD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,406 in 53 payments from 9 companies in 2025. Trend: 2023 $1,021 · 2024 $884 · 2025 $1,406
Food & beverage: $1,406
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $350 |
| Otsuka America Pharmaceutical, Inc. | 7 | $213 |
| Teva Pharmaceuticals USA, Inc. | 7 | $193 |
| ABBVIE INC. | 11 | $184 |
| Janssen Pharmaceuticals, Inc | 7 | $175 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $100 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| Alkermes, Inc. | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 3 | $52 |
Products named: COBENFY, AUSTEDO XR, VRAYLAR, ABILIFY ASIMTUFII, SPRAVATO, CAPLYTA, INGREZZA, Qelbree.
Industry payments across FL — which companies pay providers there.
